AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Nucleonics licenses key promoter technology for use in RNAi applications.

Vaccine Weekly

| July 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUL 7 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., a biotechnology company focused on the development of novel RNA interference-based (RNAi) therapeutics, has acquired an exclusive license from the University of California to intellectual property covering a class of promoters that many scientists consider the "gold standard" for transcribing expressed interfering RNAs.

Specifically, the license gives Nucleonics exclusive worldwide rights to the use of all eukaryotic RNA Pol III promoters, including human promoters, within the field of expressed interfering RNA for any human therapeutic indication. Moreover, the license covers the delivery of these promoters by either plasmid DNA or viral vectors. Through this license, ...

Related articles from newspapers, magazines, journals, and more
NUCLEONICS COMMENTS ON BENITEC V. NUCLEONICS COURT DECISION.
News wire article from: AsiaPulse News July 25, 2007 700+ words
...text of a statement. Contact details below.) Nucleonics Comments on US Court of Appeals Decision in Benitec v. Nucleonics HORSHAM, Pa.--(BUSINESS WIRE)--July 24, 2007--Nucleonics, Inc., a privately held biotechnology company...
Nucleonics Plans Appeal of Courts Dismissal of Patent Infringement Litigation...
Press release article from: Business Wire October 5, 2005 700+ words
HORSHAM, Pa. -- Nucleonics, Inc., a biotechnology company...against it by Benitec in March 2004. Nucleonics believes that the court erred on...Towarnicki, President and CEO of Nucleonics stated, "Nucleonics has maintained...
NUCLEONICS TO APPEAL COURT'S DISMISSAL OF PATENT INFRINGEMENT LITIGATION.
News wire article from: AsiaPulse News October 6, 2005 700+ words
...BUSINESS WIRE)--Oct. 5, 2005--Nucleonics, Inc., a biotechnology company focused...against it by Benitec in March 2004. Nucleonics believes that the court erred on matters...Robert Towarnicki, President and CEO of Nucleonics stated, "Nucleonics has maintained...
Nucleonics Comments on US Court of Appeals Decision in Benitec v. Nucleonics.
Press release article from: Business Wire July 24, 2007 700+ words
HORSHAM, Pa. -- Nucleonics, Inc., a privately held biotechnology company focused on...s motion to dismiss its patent infringement suit against Nucleonics. Nucleonics strongly believes that the dismissal of Nucleonics' declaratory...
NUCLEONICS FILES OBSERVATIONS IN BENITEC'S EURO PATENT CASE.
News wire article from: AsiaPulse News January 13, 2005 700+ words
...BUSINESS WIRE)--Jan. 11, 2005--Nucleonics, Inc., a biotechnology company focused...entitled "Control of Gene Expression". Nucleonics' submission provides relevant prior...time the patent application was filed. Nucleonics also believes that the claims are unclear...
NUCLEONICS GRANTED TWO PATENTS BY AUSTRALIAN PATENT OFFICE.
News wire article from: AsiaPulse News March 10, 2005 700+ words
...BUSINESS WIRE)--March 9, 2005--Nucleonics, Inc., a biotechnology company focused...and other foreign counterparts, which Nucleonics licensed on an exclusive basis in 2001...associates," said Robert Towarnicki, Nucleonics' chief executive officer. "This patent...
NUCLEONICS FILES OBSERVATIONS IN BENITEC'S POLISH PATENT PROSECUTION.
News wire article from: AsiaPulse News March 4, 2005 700+ words
...BUSINESS WIRE)--March 3, 2005--Nucleonics, Inc., a biotechnology company focused...provides relevant prior art documents that Nucleonics believes render the pending claims invalid...time the patent application was filed. Nucleonics also believes that the claims are ambiguous...
Nucleonics Files 3rd Party Observations in Benitec's European Patent...
Press release article from: Business Wire January 11, 2005 700+ words
HORSHAM, Pa. -- Nucleonics, Inc., a biotechnology company...Control of Gene Expression". Nucleonics' submission provides relevant prior...the patent application was filed. Nucleonics also believes that the claims are...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA